Search News
| 38.14 Delayed Data As of 4:03pm ET |  +0.02 / +0.05%Today’s Change | 30.20 Today|||52-Week Range 39.45 | +23.31% Year-to-Date |
| QIAGEN (QGEN) Partners DiaSorin to Extend QuantFERON Offers Sep 18 / Zacks.com - Paid Partner Content | Here's Why You Should Retain QIAGEN (QGEN) in Your Portfolio Sep 12 / Zacks.com - Paid Partner Content |
| QIAGEN Collaborates With NeuMoDx, Expands NGS Portfolio Sep 17 / Zacks.com - Paid Partner Content |
| Previous close | 38.12 |
| Today’s open | 37.85 |
| Day’s range | 37.80 - 38.20 |
| Volume | 544,434 |
| Average volume (3 months) | 920,425 |
| Market cap | $8.8B |
| Earnings growth (last year) | -51.85% |
| Earnings growth (this year) | +4.67% |
| Earnings growth (next 5 years) | +9.30% |
| Revenue growth (last year) | +5.95% |
| P/E ratio | 115.6 |
| Price/Sales | 5.08 |
| Price/Book | 3.40 |
| Today’s change | Today’s % change | |
|---|---|---|
| BIOBio Rad Laboratories... | -0.08 | -0.03% |
| PKIPerkinElmer Inc | +1.37 | +1.44% |
| BRKRBruker Corp | -0.01 | -0.03% |
| WATWaters Corp | +0.94 | +0.48% |
| Next reporting date | October 31, 2018 |
| EPS forecast (this quarter) | $0.33 |
| Annual revenue (last year) | $1.4B |
| Annual profit (last year) | $40.4M |
| Net profit margin | 2.85% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Managing Director Peer Michael Schatz |
Senior Vice President- Global Operations Douglas Liu |
Corporate headquarters Venlo, Limburg |
